The Onchocerciasis Control Programme in West Africa (OCP)

The Onchocerciasis Control Programme in West Africa (OCP) started operations in 1975. Its main objectives were to eliminate human onchocerciasis, as a disease of public-health importance and an obstacle to socio-economic development, from the Programme area. By the end of 2002, the OCP covered 11 We...

Full description

Bibliographic Details
Main Author:	Boatin, B.
Format:	Journal Article
Language:	EN
Published:	2012
Subjects:	Western Africa Animals Developing Countries Filaricides Humans Insect Control Insect Vectors Ivermectin Onchocerca volvulus Onchocerciasis Simuliidae
Online Access:	http://hdl.handle.net/10986/5061

id	okr-10986-5061
recordtype	oai_dc
spelling	okr-10986-50612021-04-23T14:02:20Z The Onchocerciasis Control Programme in West Africa (OCP) Boatin, B. Western Africa Animals Developing Countries Filaricides Humans Insect Control Insect Vectors Ivermectin Onchocerca volvulus Onchocerciasis Simuliidae The Onchocerciasis Control Programme in West Africa (OCP) started operations in 1975. Its main objectives were to eliminate human onchocerciasis, as a disease of public-health importance and an obstacle to socio-economic development, from the Programme area. By the end of 2002, the OCP covered 11 West African countries, and had introduced large-scale Mectizan (ivermectin) distribution to about 10 million people, through the communitydirected treatment approach, with treatment coverages ranging from 51%-81%. Research on large-scale Mectizan use illustrated the importance of evidence-based results, the power of multicountry studies, the need for social science in community-driven endeavours and operations research, and the value of empowering communities as allies in disease control. The generous donation of Mectizan by Merck & Co., Inc., has increased general interest in health-related public-private partnerships and generated the momentum for other donations to tackle other diseases. The vector control on which the OCP was initially based successfully interrupted the transmission of the parasite causing human onchocerciasis, Onchocerca volvulus, in many areas. The introduction of Mectizan led to the decline in anterior-segment lesions in the eye and the arrest of posterior-segment lesions. The drug continues to be highly effective in morbidity control, although recently there have been reports of sub-optimal responses in some adult O. volvulus, albeit in a few, very small and isolated foci. 2012-03-30T07:31:05Z 2012-03-30T07:31:05Z 2008 Journal Article Ann Trop Med Parasitol 0003-4983 (Print) 0003-4983 (Linking) http://hdl.handle.net/10986/5061 EN http://creativecommons.org/licenses/by-nc-nd/3.0/igo World Bank Journal Article Africa
repository_type	Digital Repository
institution_category	Foreign Institution
institution	Digital Repositories
building	World Bank Open Knowledge Repository
collection	World Bank
language	EN
topic	Western Africa Animals Developing Countries Filaricides Humans Insect Control Insect Vectors Ivermectin Onchocerca volvulus Onchocerciasis Simuliidae
spellingShingle	Western Africa Animals Developing Countries Filaricides Humans Insect Control Insect Vectors Ivermectin Onchocerca volvulus Onchocerciasis Simuliidae Boatin, B. The Onchocerciasis Control Programme in West Africa (OCP)
geographic_facet	Africa
relation	http://creativecommons.org/licenses/by-nc-nd/3.0/igo
description	The Onchocerciasis Control Programme in West Africa (OCP) started operations in 1975. Its main objectives were to eliminate human onchocerciasis, as a disease of public-health importance and an obstacle to socio-economic development, from the Programme area. By the end of 2002, the OCP covered 11 West African countries, and had introduced large-scale Mectizan (ivermectin) distribution to about 10 million people, through the communitydirected treatment approach, with treatment coverages ranging from 51%-81%. Research on large-scale Mectizan use illustrated the importance of evidence-based results, the power of multicountry studies, the need for social science in community-driven endeavours and operations research, and the value of empowering communities as allies in disease control. The generous donation of Mectizan by Merck & Co., Inc., has increased general interest in health-related public-private partnerships and generated the momentum for other donations to tackle other diseases. The vector control on which the OCP was initially based successfully interrupted the transmission of the parasite causing human onchocerciasis, Onchocerca volvulus, in many areas. The introduction of Mectizan led to the decline in anterior-segment lesions in the eye and the arrest of posterior-segment lesions. The drug continues to be highly effective in morbidity control, although recently there have been reports of sub-optimal responses in some adult O. volvulus, albeit in a few, very small and isolated foci.
format	Journal Article
author	Boatin, B.
author_facet	Boatin, B.
author_sort	Boatin, B.
title	The Onchocerciasis Control Programme in West Africa (OCP)
title_short	The Onchocerciasis Control Programme in West Africa (OCP)
title_full	The Onchocerciasis Control Programme in West Africa (OCP)
title_fullStr	The Onchocerciasis Control Programme in West Africa (OCP)
title_full_unstemmed	The Onchocerciasis Control Programme in West Africa (OCP)
title_sort	onchocerciasis control programme in west africa (ocp)
publishDate	2012
url	http://hdl.handle.net/10986/5061
_version_	1764393793104117760

The Onchocerciasis Control Programme in West Africa (OCP)

Similar Items